Epiglottitis (Haemophilus influenzae type b - Hib)

Overview


Plain-Language Overview

Epiglottitis (Haemophilus influenzae type b - Hib) is a serious infection that affects the epiglottis, a flap of tissue at the base of the tongue that helps protect the airway during swallowing. This condition primarily involves the throat and upper airway, causing swelling that can block airflow and make breathing difficult. It often develops quickly and can cause symptoms like severe sore throat, difficulty swallowing, and noisy breathing. Because the airway can become dangerously narrowed, emergency medical attention is often needed. The infection is caused by the bacteria Haemophilus influenzae type b, which used to be a common cause before widespread vaccination. Children are most commonly affected, but it can occur in adults as well. Prompt diagnosis and treatment are critical to prevent life-threatening airway obstruction.

Clinical Definition

Epiglottitis (Haemophilus influenzae type b - Hib) is an acute inflammation of the epiglottis and surrounding supraglottic structures caused predominantly by invasive infection with Haemophilus influenzae type b. The core pathology involves rapid mucosal edema and inflammation leading to potential airway obstruction. It is a medical emergency due to the risk of sudden respiratory compromise. The condition typically presents with fever, dysphagia, drooling, and stridor. Diagnosis is supported by clinical findings and confirmed by visualization of a swollen, cherry-red epiglottis on laryngoscopy or characteristic findings on lateral neck X-ray. The introduction of the Hib vaccine has dramatically reduced incidence, but it remains a critical diagnosis in unvaccinated or immunocompromised patients. Early recognition and airway management are essential to prevent morbidity and mortality.

Inciting Event

  • Colonization of the nasopharynx by Haemophilus influenzae type b precedes invasion.

  • Bacterial invasion through the mucosa of the epiglottis initiates the inflammatory process.

  • Upper respiratory viral infections may damage mucosal barriers, facilitating bacterial entry.

  • Close contact with infected individuals or asymptomatic carriers triggers transmission.

Latency Period

  • Symptoms typically develop within 1 to 3 days after bacterial invasion.

  • Rapid progression from initial sore throat to airway obstruction can occur within hours to a day.

  • The incubation period from exposure to symptom onset is usually 2 to 4 days.

Diagnostic Delay

  • Early symptoms mimic common viral pharyngitis, leading to misdiagnosis.

  • Fear of causing airway obstruction may delay throat examination and definitive diagnosis.

  • Lack of awareness in vaccinated populations can lead to low clinical suspicion.

  • Rapid progression of symptoms may outpace timely medical evaluation.

Clinical Presentation


Signs & Symptoms

  • Rapid onset of high fever and sore throat

  • Severe dysphagia and drooling

  • Muffled or 'hot potato' voice

  • Inspiratory stridor and respiratory distress

  • Anxiety and agitation due to hypoxia and airway obstruction

History of Present Illness

  • Initial presentation includes high fever, sore throat, and malaise.

  • Rapid onset of dysphagia, drooling, and muffled voice develops within hours.

  • Patients often adopt a tripod position to optimize airway patency.

  • Progressive stridor, respiratory distress, and cyanosis indicate worsening airway obstruction.

Past Medical History

  • Incomplete or absent Hib vaccination history is a key factor.

  • History of recent upper respiratory infections may be present.

  • Underlying immunodeficiency or chronic illnesses increase risk and severity.

  • No specific genetic predisposition is typically noted.

Family History

  • No known heritable syndromes are associated with epiglottitis.

  • Family members may be asymptomatic carriers of Hib, increasing transmission risk.

  • No familial clustering of epiglottitis beyond shared environmental exposure.

Physical Exam Findings

  • Tripod position with neck extended to improve airway patency

  • Drooling due to inability to swallow saliva

  • Stridor indicating upper airway obstruction

  • Muffled or hoarse voice from inflamed epiglottis

  • Tachypnea and use of accessory respiratory muscles

  • Fever reflecting systemic infection

Diagnostic Workup


Diagnostic Criteria

Diagnosis of epiglottitis is established by clinical presentation of rapid-onset sore throat, dysphagia, drooling, and respiratory distress with stridor. Definitive diagnosis is made by direct visualization of a swollen, erythematous epiglottis via laryngoscopy performed in a controlled setting to avoid airway compromise. A lateral neck X-ray may show the classic 'thumbprint sign' indicating epiglottic swelling. Blood cultures and throat swabs can identify Haemophilus influenzae type b, confirming the infectious etiology. Immediate recognition of these findings is critical for prompt airway management.

Pathophysiology


Key Mechanisms

  • Infection of the epiglottis and surrounding supraglottic structures by Haemophilus influenzae type b (Hib) leads to intense inflammatory edema and mucosal swelling.

  • Airway obstruction occurs due to the swollen epiglottis physically blocking the laryngeal inlet, causing respiratory distress.

  • Bacterial invasion triggers a robust neutrophilic inflammatory response with local tissue damage and potential for rapid progression.

  • Vascular congestion and submucosal edema further narrow the airway lumen, exacerbating symptoms of stridor and dyspnea.

InvolvementDetails
Organs

Epiglottis is the key organ affected, with inflammation causing the hallmark airway obstruction in epiglottitis.

Larynx involvement contributes to airway narrowing and respiratory distress in severe cases.

Tissues

Epiglottic mucosa is the primary site of infection and inflammation causing swelling and airway obstruction.

Submucosal connective tissue becomes edematous due to increased vascular permeability during the inflammatory response.

Cells

Neutrophils are the primary immune cells infiltrating the epiglottis, mediating acute inflammation and bacterial clearance.

Macrophages participate in phagocytosis of Haemophilus influenzae and release pro-inflammatory cytokines.

Epithelial cells of the epiglottis become inflamed and edematous, contributing to airway obstruction.

Chemical Mediators

Tumor necrosis factor-alpha (TNF-α) promotes local inflammation and vascular permeability in the epiglottis.

Interleukin-1 (IL-1) enhances recruitment of immune cells and amplifies the inflammatory response.

Histamine released from mast cells contributes to mucosal edema and airway narrowing.

Treatments


Pharmacological Treatments

  • Third-generation cephalosporins (e.g., ceftriaxone)

    • Mechanism:
      • Inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to bacterial lysis.

    • Side effects:
      • Allergic reactions

      • Diarrhea

      • Phlebitis at injection site

    • Clinical role:
      • First-line

  • Vancomycin

    • Mechanism:
      • Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of cell wall precursors, effective against resistant strains.

    • Side effects:
      • Nephrotoxicity

      • Ototoxicity

      • Red man syndrome

    • Clinical role:
      • Second-line

  • Corticosteroids (e.g., dexamethasone)

    • Mechanism:
      • Reduce airway inflammation and edema by suppressing pro-inflammatory cytokine production.

    • Side effects:
      • Hyperglycemia

      • Immunosuppression

      • Gastrointestinal bleeding

    • Clinical role:
      • Adjunctive

Non-pharmacological Treatments

  • Secure airway promptly via endotracheal intubation or tracheostomy if airway obstruction is imminent.

  • Provide supportive care including oxygen supplementation and close monitoring in an intensive care setting.

Prevention


Pharmacological Prevention

  • Hib conjugate vaccine administered in infancy to prevent invasive Haemophilus influenzae type b infections

  • Prophylactic rifampin for close contacts of patients with invasive Hib disease

Non-pharmacological Prevention

  • Routine childhood immunization schedules to ensure Hib vaccine coverage

  • Avoidance of exposure to respiratory pathogens in young children

  • Early recognition and treatment of upper respiratory infections to prevent progression

  • Public health measures to reduce transmission of Haemophilus influenzae

Outcome & Complications


Complications

  • Acute airway obstruction leading to respiratory failure

  • Bacteremia and sepsis from Haemophilus influenzae type b

  • Pneumonia as a secondary infection

  • Abscess formation in the deep neck spaces

  • Death if airway is not promptly secured

Short-term Sequelae Long-term Sequelae
  • Prolonged intubation or tracheostomy due to airway edema

  • Hypoxic brain injury from severe airway obstruction

  • Secondary bacterial pneumonia

  • Systemic inflammatory response syndrome (SIRS)

  • Airway stenosis or scarring after prolonged inflammation or intubation

  • Chronic respiratory issues if lung injury occurred

  • Psychological trauma related to critical illness and airway interventions

Differential Diagnoses


Epiglottitis (Haemophilus influenzae type b - Hib) versus Croup (Laryngotracheobronchitis)

Epiglottitis (Haemophilus influenzae type b - Hib)

Croup (Laryngotracheobronchitis)

Typically affects children aged 2 to 7 years

Commonly affects children aged 6 months to 3 years

Rapid onset with high fever and severe respiratory distress

Gradual onset with mild fever and barking cough

Thumbprint sign on lateral neck X-ray indicating swollen epiglottis

Steeple sign on neck X-ray indicating subglottic narrowing

Caused by Haemophilus influenzae type b (Hib) bacteria

Usually caused by parainfluenza virus

Epiglottitis (Haemophilus influenzae type b - Hib) versus Peritonsillar Abscess

Epiglottitis (Haemophilus influenzae type b - Hib)

Peritonsillar Abscess

Elevated white blood cell count with neutrophilia but no tonsillar exudate

Elevated white blood cell count with neutrophilia and purulent tonsillar exudate

Lateral neck X-ray shows enlarged, swollen epiglottis without abscess

CT scan shows unilateral peritonsillar fluid collection

Rapid onset of dysphagia, drooling, and muffled voice without trismus

Progressive sore throat with uvular deviation and trismus

Epiglottitis (Haemophilus influenzae type b - Hib) versus Retropharyngeal Abscess

Epiglottitis (Haemophilus influenzae type b - Hib)

Retropharyngeal Abscess

More common in children aged 2 to 7 years

More common in children under 6 years

Lateral neck X-ray shows thumbprint sign from epiglottic swelling

Lateral neck X-ray shows widened prevertebral space

Rapid onset with high fever and severe respiratory distress

Gradual onset with neck stiffness and fever

Epiglottitis (Haemophilus influenzae type b - Hib) versus Bacterial Tracheitis

Epiglottitis (Haemophilus influenzae type b - Hib)

Bacterial Tracheitis

Caused by Haemophilus influenzae type b (Hib)

Commonly caused by Staphylococcus aureus

Primary bacterial infection with rapid onset of airway obstruction

Follows viral upper respiratory infection with worsening airway obstruction

Enlarged, swollen epiglottis on lateral neck X-ray

Subglottic narrowing with irregular tracheal mucosa on imaging

Epiglottitis (Haemophilus influenzae type b - Hib) versus Foreign Body Aspiration

Epiglottitis (Haemophilus influenzae type b - Hib)

Foreign Body Aspiration

No choking episode; gradual onset of symptoms

History of choking episode or witnessed aspiration

Progressive dysphagia and respiratory distress over hours

Sudden onset of coughing, wheezing, or stridor

Lateral neck X-ray shows thumbprint sign from epiglottic swelling

Chest X-ray may show localized air trapping or radiopaque object

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.